Shares of OPKO Health, Inc. (NASDAQ:OPK – Get Rating) saw an uptick in trading volume on Thursday following insider buying activity. 1,314,757 shares were traded during mid-day trading, a decline of 57% from the previous session’s volume of 3,048,867 shares. The stock last traded at $1.17 and had previously closed at $1.13.
In particular, the major shareholder of Opko Health, Inc. purchased 14,285,714 shares of the stock in a transaction dated Thursday, January 26th. The shares were purchased at an average cost of $0.35 per share, with a total value of $4,999,999.90. Following the completion of the acquisition, the insider now owns 94,285,714 shares in the company, valued at approximately $32,999,999.90. The transaction was disclosed in a document filed with the SEC, which is available at this link. In other OPKO Health news, the major shareholder of Opko Health, Inc. bought 14,285,714 shares of OPKO Health stock in a transaction that occurred on Thursday, January 26th. The stock was acquired at an average cost of $0.35 per share, for a total transaction of $4,999,999.90. Following the completion of the transaction, the insider now directly owns 94,285,714 shares in the company, valued at $32,999,999.90. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Phillip Md Et Al Frost purchased 1,000,000 shares of the stock in a transaction on Wednesday, March 8th. The stock was acquired at an average cost of $1.18 per share, for a total transaction of $1,180,000.00. Following the acquisition, the chief executive officer now owns 199,831,694 shares in the company, valued at $235,801,398.92. The disclosure for this purchase can be found here. 40.97% of the stock is owned by insiders.
Wall Street Analyst Weigh In
Separately, HC Wainwright reaffirmed a “buy” rating and set a $3.00 price objective on shares of OPKO Health in a report on Thursday.
OPKO Health Price Performance
The firm has a 50-day moving average price of $1.27 and a 200-day moving average price of $1.58. The stock has a market capitalization of $934.91 million, a P/E ratio of -2.75 and a beta of 1.64. The company has a debt-to-equity ratio of 0.13, a quick ratio of 1.50 and a current ratio of 1.85.
OPKO Health (NASDAQ:OPK – Get Rating) last posted its quarterly earnings results on Thursday, February 23rd. The biotechnology company reported ($0.11) EPS for the quarter, putting the consensus estimate of ($0.11). The firm had revenue of $185.40 million for the quarter, compared to the consensus estimate of $168.21 million. OPKO Health had a negative net margin of 32.70% and a negative return on equity of 15.77%. The business’s revenue was down 53.8% compared to the same quarter last year. During the same period last year, the firm posted earnings per share ($0.11). On average, analysts expect that OPKO Health, Inc. will post -0.32 EPS for the current year.
Institutional Trading of OPKO Health
Hedge funds and other institutional investors have recently bought and sold shares of the stock. Guggenheim Capital LLC bought a new stake in OPKO Health during the 1st quarter valued at $38,000. Point72 Hong Kong Ltd purchased a new position in shares of OPKO Health during the first quarter valued at approximately $39,000. Humankind Investments LLC bought a new position in shares of OPKO Health during the third quarter valued at approximately $25,000. Zacks Investment Management bought a new stake in shares of OPKO Health during the 3rd quarter valued at about $25,000. Finally, Beacon Pointe Advisors LLC purchased a new position in shares of OPKO Health during the first quarter valued at about $49,000. Institutional investors own 23.49% of the company’s stock.
OPKO Health Company Profile
(Get Rating)
OPKO Health, Inc is a biopharmaceutical and diagnostics company, which engages in the provision of healthcare services. It operates through the following segments: Diagnostics and Pharmaceuticals. The Diagnostics segment includes the clinical laboratory operations of BioReference, as well as point-of-care operations.
Further Reading
Receive News & Ratings for OPKO Health Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for OPKO Health and related companies with MarketBeat.com’s FREE daily email newsletter.